UBS Group AG - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 133 filers reported holding ANIKA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$174,675
-71.2%
9,376
-59.8%
0.00%
Q2 2023$606,347
+5.8%
23,339
+17.0%
0.00%
Q1 2023$572,849
-22.3%
19,946
-19.9%
0.00%
Q4 2022$737,336
+438.2%
24,910
+330.9%
0.00%
Q3 2022$137,000
+24.5%
5,781
+16.6%
0.00%
Q2 2022$110,000
-85.0%
4,956
-83.0%
0.00%
Q1 2022$732,000
-31.3%
29,163
-2.1%
0.00%
Q4 2021$1,066,000
+22.5%
29,776
+45.7%
0.00%
Q3 2021$870,000
+98.6%
20,437
+102.0%
0.00%
Q2 2021$438,000
-45.1%
10,115
-48.3%
0.00%
Q1 2021$798,000
+1673.3%
19,565
+1884.3%
0.00%
Q4 2020$45,000
-40.0%
986
-53.3%
0.00%
Q3 2020$75,000
+70.5%
2,113
+79.8%
0.00%
Q2 2020$44,000
-78.0%
1,175
-83.0%
0.00%
Q1 2020$200,000
+2.6%
6,916
+83.9%
0.00%
Q4 2019$195,000
-90.5%
3,760
-89.9%
0.00%
-100.0%
Q3 2019$2,046,000
+173.9%
37,284
+102.9%
0.00%
Q2 2019$747,000
-77.4%
18,375
-83.2%
0.00%
-100.0%
Q1 2019$3,300,000
+37.4%
109,132
+52.7%
0.00%0.0%
Q4 2018$2,402,000
-9.4%
71,470
+13.7%
0.00%0.0%
Q3 2018$2,651,000
+58.9%
62,854
+20.6%
0.00%0.0%
Q2 2018$1,668,000
+983.1%
52,119
+1585.1%
0.00%
Q1 2018$154,000
-39.8%
3,093
-34.9%
0.00%
Q4 2017$256,000
+73.0%
4,753
+85.4%
0.00%
Q3 2017$148,000
+66.3%
2,564
+41.9%
0.00%
Q2 2017$89,000
+18.7%
1,807
+5.0%
0.00%
Q1 2017$75,000
-48.3%
1,721
-41.8%
0.00%
Q4 2016$145,000
+2.1%
2,959
-0.4%
0.00%
Q3 2016$142,000
+30.3%
2,971
+45.0%
0.00%
Q2 2016$109,000
-85.3%
2,049
-87.7%
0.00%
Q1 2016$744,000
+1081.0%
16,636
+896.8%
0.00%
Q4 2015$63,000
-23.2%
1,669
-34.4%
0.00%
Q3 2015$82,000
+17.1%
2,544
+19.5%
0.00%
Q2 2015$70,000
-89.1%
2,129
-86.4%
0.00%
Q1 2015$642,000
-37.1%
15,609
-37.7%
0.00%
-100.0%
Q4 2014$1,021,00025,0610.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders